SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR EFFICACY AND SAFETY RESULTS FROM PHASE 3 FUTURE 1 TRIAL - Mease, P. J.; Kavanaugh, A.; Reimold, A.; Tahir, H.; Rech, Jürgen; Hall, S.; Geusens, P.; Pascale, P.; Delicha, E. M.; Pricop, L.; Mpofu, S. (2017)
EVALuna2:35040